Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin (Q28267541)

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Molecular cloning, tissue-specific expression, and cellular localization of human prostasin mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Regulation of the epithelial sodium channel by serine proteases in human airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Regulation of prostasin expression and function in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

A role for the granzyme B inhibitor serine protease inhibitor 6 in CD8+ memory cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Potent and selective Kunitz domain inhibitors of plasma kallikrein designed by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Bioinformatic identification of potential autocrine signaling loops in cancers from gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

NetAffx: Affymetrix probesets and annotations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Continuous cultures of fused cells secreting antibody of predefined specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Identification and cloning of human placental bikunin, a novel serine protease inhibitor containing two Kunitz domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Biochemical characterization of prostasin, a channel activating protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Hepsin promotes prostate cancer progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200

The Serpin Protease-Nexin 1 Is Present in Rat Aortic Smooth Muscle Cells and Is Upregulated in l -NAME Hypertensive Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502119200